Global Information
회사소개 | 문의 | 비교리스트

세계의 전립선 비대증(BPH) 치료 디바이스 시장

Benign Prostatic Hyperplasia Devices

리서치사 Global Industry Analysts, Inc.
발행일 2020년 09월 상품 코드 957577
페이지 정보 영문 173 Pages
가격
US $ 4,950 ₩ 5,817,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 17,451,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 전립선 비대증(BPH) 치료 디바이스 시장 Benign Prostatic Hyperplasia Devices
발행일 : 2020년 09월 페이지 정보 : 영문 173 Pages

세계의 전립선 비대증(BPH) 치료 디바이스 시장 규모는 분석기간(2020-2027년)에 4.7%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 3억 6,200만 달러에서 2027년에는 5억 30만 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 TURP는 분석기간 중 4.7%의 CAGR을 나타내고, 2억 4,130만 달러에 달할 전망입니다.

세계의 전립선 비대증(BPH) 치료 디바이스 시장에 대해 조사했으며, 시장 점유율, 동향 및 전망, 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Boston Scientific Corporation
  • Karl Storz GmbH & Co. KG
  • Lumenis Ltd.
  • Olympus Corporation
  • Teleflex Inc.
  • Urologix, Inc.

목차

I. 서론, 조사 방법, 조사 범위

II. 개요

  • 시장 개요
    • 경쟁사의 시장 점유율
    • 경쟁사의 시장 점유율 시나리오
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향과 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 지역별 시장 분석
  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 38사
KSA 20.09.16

Global Benign Prostatic Hyperplasia Devices Market to Reach $500.3 Million by 2027

Amid the COVID-19 crisis, the global market for Benign Prostatic Hyperplasia Devices estimated at US$362 Million in the year 2020, is projected to reach a revised size of US$500.3 Million by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. TURP, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$241.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laser Therapy segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $106.7 Million, While China is Forecast to Grow at 4.5% CAGR

The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$106.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$88.8 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Other Procedures Segment to Record 4.5% CAGR

In the global Other Procedures segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$44.3 Million in the year 2020 will reach a projected size of US$60.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$55.9 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 173-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Boston Scientific Corporation
  • Karl Storz GmbH & Co. KG
  • Lumenis Ltd.
  • Olympus Corporation
  • Teleflex Inc.
  • Urologix, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Benign Prostatic Hyperplasia Devices Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 2: World Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 5: World Historic Review for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 6: World 15-Year Perspective for TURP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 8: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 11: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 17: World Historic Review for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 18: World 15-Year Perspective for ASCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 20: World Historic Review for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Urology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Benign Prostatic Hyperplasia Devices Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 22: USA Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 23: USA Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 24: USA 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 26: USA Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 27: USA 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 29: Canada Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 30: Canada 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 32: Canada Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 33: Canada 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 35: Japan Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 36: Japan 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 38: Japan Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 39: Japan 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 41: China Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 42: China 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 44: China Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 45: China 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Benign Prostatic Hyperplasia Devices Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 46: Europe Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 47: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 48: Europe 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 50: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 51: Europe 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 53: Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 54: Europe 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 56: France Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 57: France 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 59: France Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 60: France 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 62: Germany Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 63: Germany 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 65: Germany Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 66: Germany 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 68: Italy Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 69: Italy 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 71: Italy Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 72: Italy 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 74: UK Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 75: UK 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 77: UK Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 78: UK 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 79: Rest of Europe Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 80: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 81: Rest of Europe 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 82: Rest of Europe Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 83: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 84: Rest of Europe 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 85: Asia-Pacific Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 86: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 87: Asia-Pacific 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 88: Asia-Pacific Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 89: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 90: Asia-Pacific 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 91: Rest of World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 92: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 93: Rest of World 15-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 95: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, ASCs and Urology Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 96: Rest of World 15-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Urology Clinics for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 38
Back to Top
전화 문의
F A Q